Your browser doesn't support javascript.
loading
Exhaled Nitric Oxide and Pulmonary Oxygen Toxicity Susceptibility.
Fothergill, David M; Gertner, Jeffery W.
Affiliation
  • Fothergill DM; Naval Submarine Medical Research Laboratory, Groton, CT 06349-5900, USA.
  • Gertner JW; Naval Hospital Bremerton, Bremerton, WA 98312-1898, USA.
Metabolites ; 13(8)2023 Aug 08.
Article de En | MEDLINE | ID: mdl-37623874
ABSTRACT
Individual susceptibility to pulmonary oxygen toxicity (PO2tox) is highly variable and currently lacks a reliable biomarker for predicting pulmonary hyperoxic stress. As nitric oxide (NO) is involved in many respiratory system processes and functions, we aimed to determine if expired nitric oxide (FENO) levels can provide an indication of PO2tox susceptibility in humans. Eight U.S. Navy-trained divers volunteered as subjects. The hyperoxic exposures consisted of six- and eight-hour hyperbaric chamber dives conducted on consecutive days in which subjects breathed 100% oxygen at 202.65 kPa. Subjects' individual variability in pulmonary function and FENO was measured twice daily over five days and compared with their post-dive values to assess susceptibility to PO2tox. Only subjects who showed no decrements in pulmonary function following the six-hour exposure conducted the eight-hour dive. FENO decreased by 55% immediately following the six-hour oxygen exposure (n = 8, p < 0.0001) and by 63% following the eight-hour exposure (n = 4, p < 0.0001). Four subjects showed significant decreases in pulmonary function immediately following the six-hour exposure. These subjects had the lowest baseline FENO, had the lowest post-dive FENO, and had clinical symptoms of PO2tox. Individuals with low FENO were the first to develop PO2tox symptoms and deficits in pulmonary function from the hyperoxic exposures. These data suggest that endogenous levels of NO in the lungs may protect against the development of PO2tox.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Metabolites Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: CH / SUIZA / SUÍÇA / SWITZERLAND

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Metabolites Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: CH / SUIZA / SUÍÇA / SWITZERLAND